Index of /Biological Weapons/Georgia. MoH. Lugar Research Center/2018/Secret Documents/Emergent Biosolutions

	Name	Last modified	Size	Description
	Parent Directory		-
	Approval History, Letters, Reviews, and Related Documents - BAT_0/	2025-11-23 06:26	-
	Contracts/	2025-11-23 06:26	-
	link.txt	2020-06-04 12:14	43
	Links.docx	2020-06-04 04:38	17K
	75A50120Q00012 Notice of Intent Wetvax ASPR.docx	2020-06-04 03:23	19K
	Case Study-Ukraine.pdf	2020-06-02 21:19	30K
	Emergent BioSolutions Joins U.S. Government’s Warp Speed Program in Landmark Public-Private CDMO Partnership for COVID-19 Vaccine Development and Manufacturing.pdf	2020-06-03 05:11	33K
	12633-dn_20190603_1227.pdf	2020-06-02 22:58	81K
	12634-dn_20190603_1227_dod.pdf	2020-06-02 22:58	88K
	UK Department of Health-contract.pdf	2020-06-04 04:34	91K
	Emergent to deliver VIGIV to SNS for $535m.pdf	2020-06-04 04:42	159K
	Safety and Clinical Outcomes of an Equine-derived Heptavalent Botulinum Antitoxin Treatment for Confirmed or Suspected Botulism in the United States _ Clinical Infectious Diseases _ Oxford Academic.pdf	2020-06-04 03:58	171K
	Emergent Biosolutions to acquire Cangene Corp.-Canada.pdf	2020-06-02 23:38	175K
	UK Ministry of Defense-Contract.pdf	2020-06-04 04:11	201K
	The Washington Post.pdf	2020-06-04 05:00	216K
	UK Department of Health Conditions of Contract.doc	2020-06-04 04:36	264K
	Botulinum Antitoxin memoUK.pdf	2020-06-04 04:29	304K
	75A50119R00046 _ Intent to Sole Source for Sustainability and Procurement of Botulism Antitoxin.pdf	2020-06-03 04:35	361K
	2018 Annual Report.pdf	2020-06-02 23:21	3.9M